Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BYThe Lancet regional health. Europe

Age- and sex-specific smoking trends by birth cohort in Norway, 1978-2024: an analysis of cross-sectional survey data.

10 affiliations
  1. 1Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
  2. 2Massachusetts General Hospital, Center for Health Technology Assessment, Harvard Medical School, Boston, MA, USA.
  3. 3Centro de Estudios de Estado y Sociedad, Sánchez de Bustamante 27, Ciudad de Buenos Aires, Argentina.
  4. 4Unidad de Conocimiento Traslacional Hospitalaria Patagónica, Hospital SAMIC El Calafate, Av. Jorge Newbery 453, El Calafate, Santa Cruz, Argentina.
  5. 5Department of Epidemiology, University of Michigan, 1415 Washington Heights, Ann Arbor, MI, USA.
  6. 6Department of Biostatistics, Yale School of Public Health, 60 College Street, New Haven, CT, USA.
  7. 7Department Alcohol, Tobacco, and Drugs, Norwegian Institute of Public Health, Oslo, Norway.
  8. 8Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Boston, MA, USA.
  9. 9School of Population and Public Health, The University of British Columbia, 206 East Mall, Vancouver, British Columbia, Canada.
  10. 10Department of Medicine, Rutgers University, New Brunswick, NJ, USA.

Abstract

Background

Smoking is the primary cause of lung cancer, the leading cause of cancer-related mortality in Norway. To inform disease modeling and tobacco control policies, including lung cancer screening, we estimated sex-specific, birth-cohort smoking behaviors among Norwegians born between 1950 and 2000 using national survey data.Methods

We analyzed nationally representative cross-sectional survey data from 1978 to 2024 (n = 78,282) to reconstruct smoking trends and smoking intensity in Norway. We used a previously established Age-Period-Cohort modeling framework to estimate cohort-specific prevalence of daily ever-smoking, probabilities of smoking initiation and cessation, prevalence of daily current-smoking, and average cigarettes smoked per day (CPD). Analyses were conducted separately by sex assigned at birth for cohorts born between 1950 and 2000.Findings

Daily ever-smoking prevalence peaked in the 1950 birth cohort, reaching 70% (90% CI 66%-91%) among males and 66% (90% CI 55%-89%) among females, alongside similar peaks in smoking initiation probabilities, 13% (90% CI 12%-24%) for males and 12% (90% CI 10%-23%) for females. Smoking cessation probabilities increased with age within each birth cohort, rising from approximately 0% to 5% over 40 years in earlier cohorts, compared with an increase from about 5% to 15% over 20 years from the 1965 birth cohort onward. Smoking intensity peaked at 15 CPD among males and 12 CPD among females. Although smoking intensity declined in both sexes after the 1975 birth cohort, it remained higher among males, with peak model-estimated CPD decreasing from approximately 13.5 to 10 cigarettes in males and from 11.5 to 7.5 cigarettes in females between the 1980 and 2000 birth cohorts.Interpretation

Smoking behavior in Norway has changed across generations, with declining smoking initiation rates, increased smoking cessation, and lower cigarettes per day. Understanding these trends provides essential inputs to inform tobacco control and lung cancer prevention policies in Norway.Funding

Norwegian Cancer Society, National Cancer Institute of the National Institutes of Health, U.S. Food and Drug Administration.

Related

  1. Long-term trends in past-month smoking prevalence following tobacco control legislation in Chile: an age-period-cohort analysis
    Magdalena Opazo Breton, Constanza Garín Valenzuela, Guillermo Paraje
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthPMC
  2. Burden and temporal trends of cardiovascular disease among medical inpatients and age-specific and sex-specific risk of CVD-related hospitalisation at a national referral hospital in Uganda: a retrospective cohort study
    Christopher Odong, Charles Musoke, Levi Kwarisima +16
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
  3. Primary lung cancer in Palestine: advanced presentation, sex-specific smoking patterns, and systemic inflammatory burden in a hospital-based cohort
    Ahmad Thabet, Salahaldeen Deeb, Mohammad Ghannam +5
    The Egyptian Journal of Internal MedicinePeer-reviewedCC BYFull textGeneral medicineDOAJ
  4. Sex-specific health phenotypes in a large qatari cohort: a cross-sectional analysis with implications for population health policy
    Aisha Al-Khinji, Muna Rayashi, Dhafer Malouche
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  5. Sex- and age-specific trends in prescription medication use, 2005–2025: a nationwide repeated cross-sectional study
    Noémie Roland, Martin Thomsen Ernst, Jesper James Linde +2
    The Lancet Regional Health. EuropePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthDOAJEurope PMCPMC
BibTeX
@article{silvestre2026sexspecific,
  title = {{Age- and sex-specific smoking trends by birth cohort in Norway, 1978-2024: an analysis of cross-sectional survey data.}},
  author = {Jacopo Di Silvestre and M Victoria Salgado and Jihyoun Jeon and Yoonseo Mok and Theodore R Holford and Tord Finne Vedøy and Kine Pedersen and Emily A Burger and Rafael Meza},
  journal = {The Lancet regional health. Europe},
  year = {2026},
  month = oct,
  doi = {10.1016/j.lanepe.2026.101886},
  url = {https://europepmc.org/article/MED/42926883},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Age- and sex-specific smoking trends by birth cohort in Norway, 1978-2024: an analysis of cross-sectional survey data.
AU  - Jacopo Di Silvestre
AU  - M Victoria Salgado
AU  - Jihyoun Jeon
AU  - Yoonseo Mok
AU  - Theodore R Holford
AU  - Tord Finne Vedøy
AU  - Kine Pedersen
AU  - Emily A Burger
AU  - Rafael Meza
PY  - 2026
DA  - 2026/10/15
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2026.101886
UR  - https://europepmc.org/article/MED/42926883
AB  - Background  Smoking is the primary cause of lung cancer, the leading cause of cancer-related mortality in Norway. To inform disease modeling and tobacco control policies, including lung cancer screening, we estimated sex-specific, birth-cohort smoking behaviors among Norwegians born between 1950 and 2000 using national survey data.Methods  We analyzed nationally representative cross-sectional survey data from 1978 to 2024 (n = 78,282) to reconstruct smoking trends and smoking intensity in Norway. We used a previously established Age-Period-Cohort modeling framework to estimate cohort-specific prevalence of daily ever-smoking, probabilities of smoking initiation and cessation, prevalence of daily current-smoking, and average cigarettes smoked per day (CPD). Analyses were conducted separately by sex assigned at birth for cohorts born between 1950 and 2000.Findings  Daily ever-smoking prevalence peaked in the 1950 birth cohort, reaching 70% (90% CI 66%-91%) among males and 66% (90% CI 55%-89%) among females, alongside similar peaks in smoking initiation probabilities, 13% (90% CI 12%-24%) for males and 12% (90% CI 10%-23%) for females. Smoking cessation probabilities increased with age within each birth cohort, rising from approximately 0% to 5% over 40 years in earlier cohorts, compared with an increase from about 5% to 15% over 20 years from the 1965 birth cohort onward. Smoking intensity peaked at 15 CPD among males and 12 CPD among females. Although smoking intensity declined in both sexes after the 1975 birth cohort, it remained higher among males, with peak model-estimated CPD decreasing from approximately 13.5 to 10 cigarettes in males and from 11.5 to 7.5 cigarettes in females between the 1980 and 2000 birth cohorts.Interpretation  Smoking behavior in Norway has changed across generations, with declining smoking initiation rates, increased smoking cessation, and lower cigarettes per day. Understanding these trends provides essential inputs to inform tobacco control and lung cancer prevention policies in Norway.Funding  Norwegian Cancer Society, National Cancer Institute of the National Institutes of Health, U.S. Food and Drug Administration.
SN  - 2666-7762
ER  -